Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Selman, M.
space
  arrow  Pardo, A.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy

right arrow Moisés Selman, MD; Talmadge E. King, Jr., MD; and Annie Pardo, PhD

16 January 2001 | Volume 134 Issue 2 | Pages 136-151

Idiopathic pulmonary fibrosis is a progressive and usually fatal lung disease characterized by fibroblast proliferation and extracellular matrix remodeling, which result in irreversible distortion of the lung's architecture. Although the pathogenetic mechanisms remain to be determined, the prevailing hypothesis holds that fibrosis is preceded and provoked by a chronic inflammatory process that injures the lung and modulates lung fibrogenesis, leading to the end-stage fibrotic scar. However, there is little evidence that inflammation is prominent in early disease, and it is unclear whether inflammation is relevant to the development of the fibrotic process. Evidence suggests that inflammation does not play a pivotal role. Inflammation is not a prominent histopathologic finding, and epithelial injury in the absence of ongoing inflammation is sufficient to stimulate the development of fibrosis. In addition, the inflammatory response to a lung fibrogenic insult is not necessarily related to the fibrotic response. Clinical measurements of inflammation fail to correlate with stage or outcome, and potent anti-inflammatory therapy does not improve outcome. This review presents a growing body of evidence suggesting that idiopathic pulmonary fibrosis involves abnormal wound healing in response to multiple, microscopic sites of ongoing alveolar epithelial injury and activation associated with the formation of patchy fibroblast–myofibroblast foci, which evolve to fibrosis. Progress in understanding the fibrogenic mechanisms in the lung is likely to yield more effective therapies.

Author and Article Information
space

From Instituto Nacional de Enfermedades Respiratorias and Universidad Nacional Autónoma de México, Mexico City, Mexico; and the University of California, San Francisco, San Francisco, California.

Acknowledgments: The authors thank Dr. Iasha Sznajder for providing the impetus for the writing of this manuscript.

Requests for Single Reprints: Moisés Selman, MD, Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502, CP 14080, Mexico DF, Mexico; e-mail, mselman{at}conacyt.mx.

Current Author Addresses: Dr. Selman: Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502, CP 14080, Mexico DF, Mexico.

Dr. King: Department of Medicine, San Francisco General Hospital, University of California, San Francisco, 1001 Potrero Avenue, Room 5H22, San Francisco, CA 94110.

Dr. Pardo: Facultad de Ciencias, UNAM, Apartado Postal 21-630, Coyoacan, Mexico DF 04000, Mexico.




This article has been cited by other articles:


Home page
Eur Respir JHome page
F. Drakopanagiotakis, A. Xifteri, V. Polychronopoulos, and D. Bouros
Apoptosis in lung injury and fibrosis
Eur. Respir. J., December 1, 2008; 32(6): 1631 - 1638.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
T. E. King Jr and R. M. du Bois
Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 105 - 107.
[Full Text] [PDF]


Home page
ERRHome page
P. W. Noble
Epithelial fibroblast triggering and interactions in pulmonary fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 123 - 129.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
B. D. Uhal
The role of apoptosis in pulmonary fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
D. Abraham
Role of endothelin in lung fibrosis
Eur. Respir. Rev., December 1, 2008; 17(109): 145 - 150.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Tajima, M. Bando, Y. Ishii, T. Hosono, H. Yamasawa, S. Ohno, T. Takada, E. Suzuki, F. Gejyo, and Y. Sugiyama
Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice
Eur. Respir. J., November 1, 2008; 32(5): 1337 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. C. Horowitz and A. H. Limper
Stress in the ER (Endoplasmic Reticulum): A Matter of Life and Death for Epithelial Cells
Am. J. Respir. Crit. Care Med., October 15, 2008; 178(8): 782 - 783.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Ding, C. L. Gladson, H. Wu, H. Hayasaka, and M. A. Olman
Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent Manner
J. Biol. Chem., October 3, 2008; 283(40): 26839 - 26849.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Molina-Molina, A. Xaubet, X. Li, A. Abdul-Hafez, K. Friderici, K. Jernigan, W. Fu, Q. Ding, J. Pereda, A. Serrano-Mollar, et al.
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression
Eur. Respir. J., October 1, 2008; 32(4): 1004 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. K. Huang, S. H. Wettlaufer, J. Chung, and M. Peters-Golden
Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 482 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Fineschi, M. Bongiovanni, Y. Donati, S. Djaafar, F. Naso, L. Goffin, C. Barazzone Argiroffo, J.-C. Pache, J.-M. Dayer, S. Ferrari-Lacraz, et al.
In Vivo Investigations on Anti-Fibrotic Potential of Proteasome Inhibition in Lung and Skin Fibrosis
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 458 - 465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. A. Queisser, F. M. Kouri, M. Konigshoff, M. Wygrecka, U. Schubert, O. Eickelberg, and K. T. Preissner
Loss of RAGE in Pulmonary Fibrosis: Molecular Relations to Functional Changes in Pulmonary Cell Types
Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F Calabrese, F Lunardi, C Giacometti, G Marulli, M Gnoato, P Pontisso, M Saetta, M Valente, F Rea, E Perissinotto, et al.
Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations
Thorax, September 1, 2008; 63(9): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. P. Malizia, D. T. Keating, S. M. Smith, D. Walls, P. P. Doran, and J. J. Egan
Alveolar epithelial cell injury with Epstein-Barr virus upregulates TGF{beta}1 expression
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L451 - L460.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui
Interstitial lung disease guideline
Thorax, September 1, 2008; 63(Suppl_5): v1 - v58.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Eferl, P. Hasselblatt, M. Rath, H. Popper, R. Zenz, V. Komnenovic, M.-H. Idarraga, L. Kenner, and E. F. Wagner
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
PNAS, July 29, 2008; 105(30): 10525 - 10530.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Behr and J. H. Ryu
Pulmonary hypertension in interstitial lung disease
Eur. Respir. J., June 1, 2008; 31(6): 1357 - 1367.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. K. Huang and M. Peters-Golden
Eicosanoid Lipid Mediators in Fibrotic Lung Diseases: Ready for Prime Time?
Chest, June 1, 2008; 133(6): 1442 - 1450.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Yu, M. Konigshoff, A. Jayachandran, D. Handley, W. Seeger, N. Kaminski, and O. Eickelberg
Transgelin is a direct target of TGF-{beta}/Smad3-dependent epithelial cell migration in lung fibrosis
FASEB J, June 1, 2008; 22(6): 1778 - 1789.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. W. Huh, D. S. Kim, Y.-M. Oh, T. S. Shim, C. M. Lim, S. D. Lee, Y. Koh, W. S. Kim, W. D. Kim, and K. R. Kim
Is Metalloproteinase-7 Specific for Idiopathic Pulmonary Fibrosis?
Chest, May 1, 2008; 133(5): 1101 - 1106.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. S. Acharya, S. Majumdar, M. Jacob, J. Hayden, P. Mrass, W. Weninger, R. K. Assoian, and E. Pure
Fibroblast migration is mediated by CD44-dependent TGF{beta} activation
J. Cell Sci., May 1, 2008; 121(9): 1393 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers
Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Respiratory DiseaseHome page
P. Rogliani, M. Mura, M. Assunta Porretta, and C. Saltini
Review: New perspectives in the treatment of idiopathic pulmonary fibrosis
Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 75 - 93.
[Abstract] [PDF]


Home page
Eur Respir JHome page
A. Clement and E. Eber
Interstitial lung diseases in infants and children
Eur. Respir. J., March 1, 2008; 31(3): 658 - 666.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Yamasaki, H.-R. Kang, R. J. Homer, S. P. Chapoval, S. J. Cho, B. J. Lee, J. A. Elias, and C. G. Lee
P21 Regulates TGF-{beta}1-Induced Pulmonary Responses via a TNF-{alpha}-Signaling Pathway
Am. J. Respir. Cell Mol. Biol., March 1, 2008; 38(3): 346 - 353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. M. Englert, L. E. Hanford, N. Kaminski, J. M. Tobolewski, R. J. Tan, C. L. Fattman, L. Ramsgaard, T. J. Richards, I. Loutaev, P. P. Nawroth, et al.
A Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Am. J. Pathol., March 1, 2008; 172(3): 583 - 591.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. M. Reich, I. Noth, and F. J. Martinez
Genesis of Some Histologic, BAL, and Auscultatory Features of Idiopathic Pulmonary Fibrosis
Chest, February 1, 2008; 133(2): 585 - 586.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J.-F. Marquis, A. Nantel, R. LaCourse, L. Ryan, R. J. North, and P. Gros
Fibrotic Response as a Distinguishing Feature of Resistance and Susceptibility to Pulmonary Infection with Mycobacterium tuberculosis in Mice
Infect. Immun., January 1, 2008; 76(1): 78 - 88.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. K. Huang, S. H. Wettlaufer, C. M. Hogaboam, K. R. Flaherty, F. J. Martinez, J. L. Myers, T. V. Colby, W. D. Travis, G. B. Toews, and M. Peters-Golden
Variable Prostaglandin E2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2008; 177(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. Kitowska, D. Zakrzewicz, M. Konigshoff, I. Chrobak, F. Grimminger, W. Seeger, P. Bulau, and O. Eickelberg
Functional role and species-specific contribution of arginases in pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L34 - L45.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Wallach-Dayan, R. Golan-Gerstl, and R. Breuer
Evasion of myofibroblasts from immune surveillance: A mechanism for tissue fibrosis
PNAS, December 18, 2007; 104(51): 20460 - 20465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Azuma, Y. Nishioka, Y. Aono, M. Inayama, H. Makino, J. Kishi, M. Shono, K. Kinoshita, H. Uehara, F. Ogushi, et al.
Role of {alpha}1-Acid Glycoprotein in Therapeutic Antifibrotic Effects of Imatinib with Macrolides in Mice
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1243 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Fujimoto, C. N. D'Alessandro-Gabazza, M. S. S. Palanki, P. E. Erdman, T. Takagi, E. C. Gabazza, N. E. Bruno, Y. Yano, T. Hayashi, S. Tamaki, et al.
Inhibition of Nuclear Factor-{kappa}B in T Cells Suppresses Lung Fibrosis
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1251 - 1260.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A. Faress, D. E. Nethery, E. F. O. Kern, R. Eisenberg, F. J. Jacono, C. L. Allen, and J. A. Kern
Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2
J Appl Physiol, December 1, 2007; 103(6): 2077 - 2083.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Tzouvelekis, V. Harokopos, T. Paparountas, N. Oikonomou, A. Chatziioannou, G. Vilaras, E. Tsiambas, A. Karameris, D. Bouros, and V. Aidinis
Comparative Expression Profiling in Pulmonary Fibrosis Suggests a Role of Hypoxia-inducible Factor-1{alpha} in Disease Pathogenesis
Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1108 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya
The role of the receptor for advanced glycation end-products in lung fibrosis
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1427 - L1436.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
L. S Mackay, R. L Anderson, G. Parry, J. Lordan, P. A Corris, and A. J Fisher
Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation
Thorax, December 1, 2007; 62(12): 1069 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Marchal-Somme, Y. Uzunhan, S. Marchand-Adam, M. Kambouchner, D. Valeyre, B. Crestani, and P. Soler
Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease
Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. M. Maher, A. U. Wells, and G. J. Laurent
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Eur. Respir. J., November 1, 2007; 30(5): 835 - 839.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. R. Collard, B. B. Moore, K. R. Flaherty, K. K. Brown, R. J. Kaner, T. E. King Jr., J. A. Lasky, J. E. Loyd, I. Noth, M. A. Olman, et al.
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 636 - 643.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Zhang, W. E. Lawson, V. V. Polosukhin, A. Pozzi, T. S. Blackwell, Y. Litingtung, and C. Chiang
Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in Mice
Am. J. Pathol., October 1, 2007; 171(4): 1113 - 1126.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
N. Odajima, T. Betsuyaku, Y. Nasuhara, and M. Nishimura
Loss of Caveolin-1 in Bronchiolization in Lung Fibrosis
J. Histochem. Cytochem., September 1, 2007; 55(9): 899 - 909.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
G. W. Hunninghake and M. I. Schwarz
State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis?: A Perspective
Proceedings of the ATS, August 15, 2007; 4(5): 449 - 452.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest, August 1, 2007; 132(2): 637 - 650.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
R. M. du Bois
Blocking endothelin: breaking new ground
Eur. Respir. Rev., August 1, 2007; 16(102): 24 - 29.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer
Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis
Eur. Respir. J., August 1, 2007; 30(2): 205 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. Kass, R. S. Bridges, A. Borczuk, and S. Greenberg
Methionine Aminopeptidase-2 as a Selective Target of Myofibroblasts in Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., August 1, 2007; 37(2): 193 - 201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. K. Kim and H. A. Chapman
Endothelin-1 as Initiator of Epithelial-Mesenchymal Transition: Potential New Role for Endothelin-1 during Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 1 - 2.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Dell'Aica, R. Niero, F. Piazza, A. Cabrelle, L. Sartor, C. Colalto, E. Brunetta, G. Lorusso, R. Benelli, A. Albini, et al.
Hyperforin Blocks Neutrophil Activation of Matrix Metalloproteinase-9, Motility and Recruitment, and Restrains Inflammation-Triggered Angiogenesis and Lung Fibrosis
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 492 - 500.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 875 - 880.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Cuzzocrea, T. Genovese, M. Failla, G. Vecchio, M. Fruciano, E. Mazzon, R. Di Paola, C. Muia, C. La Rosa, N. Crimi, et al.
Protective effect of orally administered carnosine on bleomycin-induced lung injury
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1095 - L1104.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Vittal, H. Zhang, M. K. Han, B. B. Moore, J. C. Horowitz, and V. J. Thannickal
Effects of the Protein Kinase Inhibitor, Imatinib Mesylate, on Epithelial/Mesenchymal Phenotypes: Implications for Treatment of Fibrotic Diseases
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. V. Gonzalez, F. Le Bellego, and M. S. Ludwig
Imbalance of Receptor-Regulated and Inhibitory Smads in Lung Fibroblasts from Bleomycin-Exposed Rats
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 206 - 212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Y. Sanders, P. Kumbla, and J. S. Hagood
Enhanced Myofibroblastic Differentiation and Survival in Thy-1(-) Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Huang, S. H. Wettlaufer, C. Hogaboam, D. M. Aronoff, and M. Peters-Golden
Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L405 - L413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Gazdhar, P. Fachinger, C. van Leer, J. Pierog, M. Gugger, R. Friis, R. A. Schmid, and T. Geiser
Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis
Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L529 - L536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. O. Rosas and N. Kaminski
When It Comes to Genes--IPF or NSIP, Familial or Sporadic--They're All the Same
Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 5 - 6.
[Full Text]